Inventor
Andrew T. Watt
Inventor
Vista, CA, US
Overview
Patents· 29 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes31%
A61KPreparations for medical, dental or toiletry purposes30%
Y02PClimate change mitigation technologies in the production or processing of goods23%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations6%
C12YEnzymes4%
C07HSugars2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
A01KAnimal husbandry1%
PatentTitleYear
10,858,657Methods for treating hypercholesterolemia20209,650,636'Methods for treating hypercholesterolemia'20178,912,160'Methods for treating hypercholesterolemia'20148,664,190'Methods for treating hypercholesterolemia'20148,093,222'Methods for treating hypercholesterolemia'20128,084,437'Methods for treating hypercholesterolemia'20117,846,730'Antisense modulation of BCL2-associated X protein expression'20107,709,453'Modulation of the RNA interference pathway'20107,709,630'Antisense modulation of connective tissue growth factor expression'20107,427,470'Antisense modulation of helicase-moi expression'20086,965,025'Antisense modulation of connective tissue growth factor expression'20056,870,046'Antisense modulation of interferon gamma receptor 2 expression'20056,867,039'Antisense modulation of dual specific phosphatase 5 expression'20056,825,337'Antisense modulation of PLML expression'20046,734,017'Antisense modulation of vascular endothelial growth factor receptor-2 expression'20046,710,174'Antisense inhibition of vascular endothelial growth factor receptor-1 expression'20046,656,732'Antisense inhibition of src-c expression'20036,566,135'Antisense modulation of caspase 6 expression'20036,566,132'Antisense modulation of Interferon gamma receptor 1 expression'20036,551,826'Antisense modulation of raidd expression'20036,492,170'Antisense modulation of caspase 9 expression'20026,468,795'Antisense modulation of Apaf-1 expression'20026,468,796'Antisense modulation of bifunctional apoptosis regulator expression'20026,448,080'Antisense modulation of WRN expression'20026,444,466'Antisense modulation of helicase-moi expression'20026,436,706'Antisense inhibitor of RECQL4 expression'20026,410,324'Antisense modulation of tumor necrosis factor receptor 2 expression'20026,410,325'Antisense modulation of phospholipase A2, group VI (Ca2-independent) expression'20026,399,378'Antisense modulation of RECQL2 expression'2002Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2002–2017Patents assigned to ISIS PHARMACEUTICALS INC (28)· patent assignee history
2002–2010Based in Vista, CA, US· patent location history
2010Based in Oceanside, CA, US· patent location history
2011–2014Patents assigned to BHANOT SANJAY (3)· patent assignee history
2011–2014Patents assigned to CROOKE ROSANNE M (3)· patent assignee history
2011–2014Patents assigned to FREIER SUSAN M (3)· patent assignee history
2011–2014Patents assigned to GRAHAM MARK J (3)· patent assignee history
2011–2014Based in Carlsbad, CA, US· patent location history
2014–2020Based in San Diego, CA, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ISIS PHARMACEUTICALS INC | 28 | 2002–2017 |
| BHANOT SANJAY | 3 | 2011–2014 |
| CROOKE ROSANNE M | 3 | 2011–2014 |
| FREIER SUSAN M | 3 | 2011–2014 |
| GRAHAM MARK J | 3 | 2011–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Vista, California, US | 21 | 2002–2010 |
| San Diego, California, US | 3 | 2014–2020 |
| Carlsbad, California, US | 3 | 2011–2014 |
| Oceanside, California, US | 2 | 2010 |